Business

Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

Not for distribution to United States newswire services or for dissemination in the United States...

articleDiagnos Inc.November 25, 20253/company/diagnos-inc/news/diagnos-announces-upsize-of-previously-announced-brokered-private-placement-to-dollar365m-led-by-centurion-one-capital
Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

About this update from Diagnos Inc.

[{"type":"text","content":"Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital\n\n\n\n\n Not for distribution to United States newswire services or for dissemination in the United States.\n \n\n\n BROSSARD, Québec, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“\n \n DIAGNOS\n \n ” or the “\n \n Company\n \n ”) (TSXV: ADK and OTCQB: DGNOF) is pleased to announce that it has upsized its brokered private placement as previously announced in its press release dated November 10, 2025, due to strong investor demand. Under the amended terms, the Company will issue up to 12,166,667 units (“\n \n Units\n \n ”) of the Company at $0.30 per Unit (the “\n \n Issue Price\n \n ”) for aggregate gross proceeds of up to approximately $3,650,000 (the “\n \n Offering\n \n ”).\n \n\n Each Unit shall consist of one common share in the capital of the Company (each, a “\n \n Share\n \n ”) and one common share purchase warrant (each, a “\n \n Warrant\n \n ”). Each full Warrant shall entitle the holder thereof to purchase one Share (a “\n \n Warrant Share\n \n ”) at a price of $0.40 for a period of eighteen (18) months following the Closing Date (as defined herein). In connection with the Offering, the Company has also granted the Agent an opinion exercisable at any time prior to 2 business days prior to the last closing of the Offering to increase the size of the Offering by an additional 1,750,000 Units for aggregate gross proceeds of up to approximately an additional $525,000.\n \n\n The Offering is led by Centurion One Capital Corp. (the “\n \n Lead Agent\n \n ”) as lead agent and sole bookrunner.\n \n\n The gross proceeds of the Offering will be used for regulatory affairs, product development, business development and general corporate purposes.\n \n\n Subject to compliance with applicable laws, the Units to be issued under the Offering will be offered by way of private placement in each of the provinces of British Columbia, Alberta, Ontario and Quebec, in the United States pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), and in jurisdictions outside of Canada and the Unite...

More updates from Diagnos Inc.